Projects

RNDr. Alexandra Kisucká, PhD.

International

Finished
  • The potential protective role of siponimod in neurodegeneration/spinal cord injury.
    Program: Mobility
    Duration: 1. 1. 2023 – 31. 12. 2024
  • The response of nitric oxide synthase and calcium-binding proteins in brain stem after spinal cord injury
    Program: Inter-academic agreement
    Duration: 1. 1. 2010 – 31. 12. 2012
  • The effect of endurance training on NOS and parvalbumin activity in proprioceptive afferentation if the spinal cord
    Program: Inter-academic agreement
    Duration: 1. 1. 2007 – 31. 12. 2009

National

Current
  • Regulatory mechanisms of mutual communication between hypoxia-ischemia and inflammation during the acute and subacute phase of traumatic spinal cord injury and Siponimod treatment
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • Neuroprotective and regenerative potential of post-traumatic cure targeted to Angiotensin II receptors
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
Finished
  • Remote conditioning as a prevention and treatment of cerebral ischemia associated with hyper-inflammatory reaction (simulation of COVID-19)
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2024
  • The development of translationally relevant regenerative and reparative strategies after spinal cord trauma
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Regulation of M1/M2 polarization: the effect on neuron survival, axonal growth and functional recovery after spinal cord trauma
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2023
  • The neuroprotection of synergic effect of the AT1 receptor blockade and AT2 receptor stimulation after traumatic spinal cord injury
    Program: SRDA
    Duration: 1. 7. 2019 – 30. 6. 2023
  • Open scientific community for modern interdisciplinary research in medicine
    Program:
    Duration: 1. 11. 2019 – 30. 6. 2023
  • Neuroprotection in the process of ischemic tolerance acquisition from the perspective of rat brain pathways monitoring (proteomic MALDI-TOF/TOF study)
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
  • The application of combined therapy to suppress secondary damage after spinal cord trauma
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 10. 2020
  • Formation and development of a diagnostic procedure in the treatment of trauma - injured spinal cord
    Program: EU Structural Funds Research & Development
    Duration: 1. 11. 2010 – 30. 4. 2015
  • Modulation somato-sensory neural pathways by Angiotensin II. Effect of Angiotensin II receptor blockade on nociceptive signaling.
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2012
  • Science in Slovakia - if we do not know something, we do not feel need for it.
    Program: SRDA
    Duration: 3. 9. 2009 – 31. 8. 2012
  • The disturbance of NO/cGMP signaling pathway in cervical spinal cord injury
    Program: VEGA
    Duration: 1. 1. 2008 – 31. 12. 2010
  • Causal genesis of spasticity and therapeutic possibilities.
    Program: SRDA
    Duration: 7. 2. 2007 – 30. 6. 2010
  • The participation of nitric oxide synthase on nociceptive and proprioceptive afferentation
    Program: VEGA
    Duration: 1. 1. 2005 – 31. 12. 2007
Employees